Chemotherapy for esophageal cancer must be performed at the correct stage of the disease

The rapid development of medical technology has made chemotherapy the main way to control cancer. However, for esophageal cancer, the effects of chemotherapy at different stages of the disease are different, and chemotherapy alone cannot effectively control the disease.

Most patients with esophageal cancer will undergo surgical treatment, but there will be a series of follow-up treatment measures after the operation, including esophageal cancer chemotherapy, radiotherapy, cellular immunotherapy, etc. Postoperative chemotherapy for esophageal cancer is a must for most malignant tumors, but the choice of chemotherapy method and range should be differentiated according to the different conditions of the patients.

Patients with early esophageal cancer are generally in good health, and the complete resection rate of surgery is very high. The main problems of postoperative treatment are the damage to the human immune system caused by surgery, the prevention of postoperative recurrence, and the inhibition of latent cancer cells. Chemotherapy for esophageal cancer mainly acts directly on the cancer cells that have already formed, and its toxic side effects often damage the human immune system. Therefore, chemotherapy for esophageal cancer is not suitable for postoperative treatment of early esophageal cancer.

Surgical treatment for patients with advanced esophageal cancer is mostly palliative resection. Chemotherapy is one of the more effective postoperative treatments for esophageal cancer, and the efficacy of combined chemotherapy is better than single-drug chemotherapy. However, chemotherapy has significant side effects and often damages the human immune system. In addition, the physical condition of patients with advanced esophageal cancer is generally poor after surgery. Many patients are extremely weak after several courses of chemotherapy and cannot continue treatment. Some patients with very poor physical conditions cannot undergo chemotherapy at all.

It is hoped that by understanding the different effects of chemotherapy on esophageal cancer at the same stage of the disease, patients will be able to choose the correct treatment method at the appropriate time, which will achieve the best effect in treating and controlling the disease.

For more information, please visit the esophageal cancer disease special topic at http://www..com.cn/zhongliu/sda/ or consult an expert for free. The expert will then give a detailed answer based on the patient's specific situation.